Dementia Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Growing Aging Population as well as Rise in Healthcare Infrastructure
   3. Market Restraints
      1. Limited Treatment Efficacy
      2. High Cost of Care
   4. Market Opportunities
      1. Rise in the Investment for R&D By Public and Private Organizations
   5. Market Trends
      1. Emphasis on Early Detection and Intervention
      2. Integration of Digital Health Solutions
5. MARKET SEGMENTATION
   1. By Type
      1. Alzheimer's Disease Dementia
      2. Vascular Dementia
      3. Dementia With Lewy Bodies (Dlb)
      4. Parkinson's Disease Dementia
      5. Mixed Dementia
      6. Frontotemporal Dementia
   2. By Drug Class
      1. MAO Inhibitors
      2. Glutamate Inhibitors
      3. Cholinesterase Inhibitors
      4. Others
   3. By Therapy type
      1. Cognitive Stimulation Therapy
      2. Cognitive Behavioral Therapy (CBT)
   4. By Route of Administration
      1. Oral
      2. Parenteral
   5. By End Use
      1. Clinic
      2. Hospital
      3. Others
   6. By Distribution Channel
      1. Hospital Pharmacy
      2. Special clinics
      3. Others
   7. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. Allergan
      2. Aurobindo Pharma
      3. Amneal Pharmaceuticals LLC
      4. Alembic Pharmaceuticals Limited
      5. Cipla Inc
      6. Dr. Reddy’s Laboratories Ltd
      7. Eisai Co., Ltd.
      8. Hikma Pharmaceuticals PLC
      9. Johnson & Johnson Services, Inc
      10. Jubilant Life Sciences Ltd
      11. Lannett
      12. LUPIN
      13. Mylan N.V.
      14. Novartis AG
      15. Sun Pharmaceutical Industries Ltd
      16. Zydus Cadila
      17. Torrent Pharmaceuticals Ltd
      18. Teva Pharmaceutical Industries Ltd
7. MARKET OPPORTUNITIES AND FUTURE TRENDS

Frequently Asked Questions

Q.1. What is the projected market value of the global Dementiamarket?

The global market of Dementia is projected to reach USD 30 Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Dementiamarket?

The global Dementia market has an estimated annual growth rate of 6.2% .

Q.3. What are the recent trends of Dementiamarket?

Emphasis on early detection and intervention and integration of digital health solutionsare some of the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in Dementia?

The major companies profiled in this report include Allergan, Aurobindo Pharma, Amneal Pharmaceuticals LLC, Alembic Pharmaceuticals Limited, Cipla Inc, Dr. Reddy’s Laboratories Ltd, Eisai Co., Ltd., Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc, Jubilant Life Sciences Ltd, Lannett, LUPIN, Mylan N.V., Novartis AG, Sun Pharmaceutical Industries Ltd, Zydus Cadila, Torrent Pharmaceuticals Ltd, Teva Pharmaceutical Industries Ltd, among others.

Q.5. Which region is estimated to held highest CAGR inDementiamarket?

North America is estimated to hold biggest share in the market for Dementia.